Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yerby, M. S.
Right arrow Articles by Wilensky, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yerby, M. S.
Right arrow Articles by Wilensky, A. J.
NEUROLOGY 1987;37:1224
© 1987 American Academy of Neurology

Serum prolactins in the diagnosis of epilepsy

Sensitivity, specificity, and predictive value

M. S. Yerby, MD, MPH, G. van Belle, PhD, P. N. Friel, BS and A. J. Wilensky, MD

Epilepsy Center, Department of Neurological Surgery, School of Medicine, and the Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA.

Serum prolactin levels rise after generalized tonic-clonic and partial complex seizures, but not after pseudoepileptic seizures. The criteria for a significant elevation in serum prolactin vary with individual investigators. The prevalence of pseudoseizures in the population studied determines the predictive value of serum prolactin determinations. In populations where most patients have epilepsy, a rise in serum prolactin is highly predictive for true epilepsy, but no increase in serum prolactin is not predictive for pseudoseizures.

Address correspondence and reprint requests to Dr. Yerby, Epilepsy Center ZA-50, Harborview Medical Center, 325 9th Avenue, Seattle, WA 98104.

Supported by NIH grant #NS-17111.

Received April 7, 1986. Accepted for publication in final form October 31, 1986.




This article has been cited by other articles:


Home page
NeurologyHome page
D. K. Chen, Y. T. So, and R. S. Fisher
Use of serum prolactin in diagnosing epileptic seizures: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurology, September 13, 2005; 65(5): 668 - 675.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. T. Longstreth Jr, T. D. Koepsell, and G. van Belle
Clinical Neuroepidemiology: I. Diagnosis
Arch Neurol, October 1, 1987; 44(10): 1091 - 1099.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.